Insider Trading & Ownership - Kariv Tomer

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kariv Tomer
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-05-13
Purchase
2021-05-17
07:00 am
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
5,925,925$1.35$7,999,9997,804,778
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:39 pm
Keros Therapeutics Inc.KROSKariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000$50$3,000,000155,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:13 pm
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
437,499$16$6,999,984149,262
(Indirect)
View
2019-11-11
Purchase
2019-11-13
7:10 pm
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
250,000$16$4,000,0001,134,671
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:48 pm
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
200,000$9$1,800,0007,212,186
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-06
Option Award
2023-06-08
4:45 pm
N/A
2033-06-05
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
10,000$010,000
(Direct)
View
2023-01-30
Option Award
2023-01-31
4:08 pm
N/A
2033-01-30
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
2,859$02,859
(Direct)
View
2022-11-29
Exercise
2022-11-30
4:38 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
7,176$01,226,412
(Indirect)
View
2022-11-29
Exercise
2022-11-30
4:38 pm
N/A
N/A
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
7,176$0.00011,226,412
(Indirect)
View

Ownership(A)
2022-11-30
4:34 pm
N/A
2023-10-07
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
0$07,176
(Indirect)
View
2022-06-15
Option Award
2022-06-17
08:24 am
N/A
2032-06-15
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
20,000$020,000
(Direct)
View
2022-06-01
Option Award
2022-06-03
4:27 pm
N/A
2032-05-31
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
8,293$08,293
(Direct)
View
2021-06-01
Option Award
2021-06-03
5:31 pm
N/A
2031-05-31
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
8,293$08,293
(Direct)
View
2021-05-19
Option Award
2021-05-20
4:10 pm
N/A
2031-05-19
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
20,000$020,000
(Direct)
View
2020-05-20
Option Award
2020-05-22
4:10 pm
N/A
2030-05-20
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
20,000$020,000
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
3,545,100$0149,262
(Indirect)
View

Ownership
2020-04-07
7:30 pm
N/A
N/A
Keros Therapeutics Inc.KROSKariv Tomer
Director
10% Owner
0$04,297,008
(Indirect)
View
2019-12-19
Option Award
2019-12-20
8:00 pm
N/A
2029-12-19
LogicBio Therapeutics Inc.LOGCKariv Tomer
Director
10,869$010,869
(Direct)
View
2019-11-13
Conversion
2019-11-13
7:10 pm
N/A
N/A
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Pontifax Late Stage GP Ltd.
Pontifax Late Stage Fund L.P.
Director
10% Owner
6,384,672$01,134,671
(Indirect)
View

Ownership
2019-11-08
7:17 pm
N/A
N/A
89bio Inc.ETNBKariv Tomer
Pontifax (Israel) V L.P.
Pontifax (Cayman) V L.P.
Pontifax (China) V L.P.
Pontifax 5 G.P. L.P.
Pontifax Management 4 G.P. (2015) Ltd.
Director
10% Owner
0$0884,671
(Indirect)
View
2019-05-29
Option Award
2019-05-29
5:13 pm
N/A
2029-05-29
Eloxx Pharmaceuticals Inc.ELOXKariv Tomer
Director
20,000$020,000
(Direct)
View
(A) Indicate amendment filing.